Skip to content

The effect of ajor oil on knee osteoarthritis

The effect of topical application of ajor oil on clinical indicators of knee osteoarthritis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190406043175N8
Enrollment
80
Registered
2022-10-02
Start date
2022-10-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: Ajor oil is made by the Pharmacological Research Center of Medicinal Plants. Its chemical composition consists of olive oil and brick’s solutes. The concentration o

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Primary symptomatic osteoarthritis in at least one knee confirmed by clinical or radiological criteria (American College of Rheumatology (ACR) criteria). No adequate response to medical treatment (Meloxicam) after at least two weeks of administration before the start of the study. A baseline visual analog scale (VAS) score higher than 30 at the beginning of the study. Patients aged 40 to 80 years

Exclusion criteria

Exclusion criteria: The intra-articular injection of hyaluronic acid in the three months before the start of the study The 4-week treatment with oral corticosteroids before the start of the study Patients with a history of deep vein thrombosis Active liver or renal disease and malignancies Secondary osteoarthritis or suspected Patients treated with hormonal drugs Patients treated with anticoagulation drugs Patients with a history of ischemic or hemorrhagic stroke

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Early intervention, four weeks after the intervention, eight weeks after intervention. Method of measurement: Western Ontario and McMasters Universities Osteoarthritis Index (Womac) questionnaire and Visual Analog Scale (VAS).;Joint stiffness. Timepoint: Early intervention, four weeks after the intervention, eight weeks after intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC)questionnaire and Visual Analog Scale (VAS).;Physical performance. Timepoint: Early intervention, four weeks after the intervention, eight weeks after intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC)questionnaire and Visual Analog Scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Rakhshandeh

Mashhad University of Medical Sciences

rakhshandehh@mums.ac.ir+98 51 3800 2259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026